These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 15078930)
1. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. DeMeritt IB; Milford LE; Yurochko AD J Virol; 2004 May; 78(9):4498-507. PubMed ID: 15078930 [TBL] [Abstract][Full Text] [Related]
2. The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha. Nogalski MT; Podduturi JP; DeMeritt IB; Milford LE; Yurochko AD J Virol; 2007 May; 81(10):5305-14. PubMed ID: 17344282 [TBL] [Abstract][Full Text] [Related]
3. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Caposio P; Luganini A; Hahn G; Landolfo S; Gribaudo G Cell Microbiol; 2007 Aug; 9(8):2040-54. PubMed ID: 17419715 [TBL] [Abstract][Full Text] [Related]
4. The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells. Caposio P; Luganini A; Bronzini M; Landolfo S; Gribaudo G J Virol; 2010 May; 84(9):4481-93. PubMed ID: 20147408 [TBL] [Abstract][Full Text] [Related]
5. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. Yurochko AD; Mayo MW; Poma EE; Baldwin AS; Huang ES J Virol; 1997 Jun; 71(6):4638-48. PubMed ID: 9151857 [TBL] [Abstract][Full Text] [Related]
6. Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression. DeMeritt IB; Podduturi JP; Tilley AM; Nogalski MT; Yurochko AD Virology; 2006 Mar; 346(1):15-31. PubMed ID: 16303162 [TBL] [Abstract][Full Text] [Related]
7. Biphasic regulation of A20 gene expression during human cytomegalovirus infection. Gu SY; Kim YE; Kwon KM; Han TH; Ahn JH Virol J; 2014 Jul; 11():124. PubMed ID: 25005727 [TBL] [Abstract][Full Text] [Related]
8. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages. Khan KA; Coaquette A; Davrinche C; Herbein G J Immunol; 2009 Jun; 182(12):7784-94. PubMed ID: 19494302 [TBL] [Abstract][Full Text] [Related]
9. The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection. Isern E; Gustems M; Messerle M; Borst E; Ghazal P; Angulo A J Virol; 2011 Feb; 85(4):1732-46. PubMed ID: 21106746 [TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha. Clifton DR; Rydkina E; Freeman RS; Sahni SK Infect Immun; 2005 Jan; 73(1):155-65. PubMed ID: 15618150 [TBL] [Abstract][Full Text] [Related]
11. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Caposio P; Musso T; Luganini A; Inoue H; Gariglio M; Landolfo S; Gribaudo G Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604 [TBL] [Abstract][Full Text] [Related]
12. Modulation of human cytomegalovirus immediate-early gene enhancer by mitogen-activated protein kinase kinase kinase-1. Sun B; Harrowe G; Reinhard C; Yoshihara C; Chu K; Zhuo S J Cell Biochem; 2001; 83(4):563-73. PubMed ID: 11746500 [TBL] [Abstract][Full Text] [Related]
13. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter. Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358 [TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. Yurochko AD; Kowalik TF; Huong SM; Huang ES J Virol; 1995 Sep; 69(9):5391-400. PubMed ID: 7636984 [TBL] [Abstract][Full Text] [Related]
15. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity. Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925 [TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889 [TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation can mediate inhibition of human cytomegalovirus replication. Eickhoff JE; Cotten M J Gen Virol; 2005 Feb; 86(Pt 2):285-295. PubMed ID: 15659747 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation. Peng Y; Power MR; Li B; Lin TJ J Leukoc Biol; 2005 Jun; 77(6):975-83. PubMed ID: 15784689 [TBL] [Abstract][Full Text] [Related]